PMID: 11907916Mar 23, 2002Paper

A cohort study of hormone replacement therapy given to women previously treated for breast cancer

Climacteric : the Journal of the International Menopause Society
J DewB Wren

Abstract

Women who have been previously treated for breast cancer are usually advised to avoid hormone therapy for fear of increasing their risk of tumor recurrence. However, for some women, menopausal symptoms are so severe that their quality of life is poor. Because ethic committees are reticent to permit a double-blind randomized trial, we performed a cohort study of hormone therapy after breast cancer. The study group comprised 1472 women with breast cancer. A total of 167 subjects had used an oral or transdermal estrogen after their treatment for breast cancer. Amongst these estrogen users, 152 (91%) had also used a progestin. In total, 106 other women had used a progestin alone as a treatment for menopausal flushes and not as a treatment for breast cancer. Cox regression analysis was performed using estrogen as a time-dependent covariate with disease-free interval as the outcome. The uncorrected hazard ratio for the estrogen-progestin users was 0.67 (95% confidence interval (CI) 0.38-1.16) and for the progestin alone users was 0.85 (95% CI 0.44-1.65). This study was unable to demonstrate a significant increase in risk of breast cancer recurrence for women who used HRT and suggests that the time is now appropriate for a randomized ...Continue Reading

References

May 1, 1990·Endocrine Reviews·C L Clarke, R L Sutherland
Jan 1, 1989·Hormone Research·C Rose, H T Mouridsen
Dec 15, 1988·International Journal of Cancer. Journal International Du Cancer·M Ewertz
Sep 26, 1980·JAMA : the Journal of the American Medical Association·I SchiffK J Ryan
Feb 1, 1995·Journal of the National Cancer Institute·P G TonioloB S Pasternack
Sep 23, 1944·British Medical Journal·A HaddowP C Koller

❮ Previous
Next ❯

Citations

Jun 29, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Susan ThompsonCharles L Loprinzi
Mar 28, 2008·Archives of Pharmacal Research·Seung Min OhKyu Hyuck Chung
Jul 31, 2004·Maturitas·Nicoletta BigliaPiero Sismondi
Dec 22, 2005·Maturitas·Pelin BaturMeng Xu
Mar 5, 2004·Surgical Oncology·J M Dixon
May 20, 2003·Maturitas·Nicoletta BigliaPiero Sismondi
Jun 18, 2002·The Lancet Oncology·Jo Marsden
Jul 1, 2005·Breast Cancer Research : BCR·Nananda F ColRowan T Chlebowski
Oct 6, 2001·Drugs & Aging·D BartonD Wahner-Roedler
Oct 28, 2006·Gynäkologisch-geburtshilfliche Rundschau·Nicoletta BigliaPiero Sismondi
Jan 14, 2010·Climacteric : the Journal of the International Menopause Society·M KontosI S Fentiman
Jan 27, 2005·Climacteric : the Journal of the International Menopause Society·E M DurnaB G Wren
Mar 23, 2002·Climacteric : the Journal of the International Menopause Society·A H MacLennan
Jan 24, 2006·Climacteric : the Journal of the International Menopause Society·P GuptaI Paterson
Jul 18, 2006·The Journal of Steroid Biochemistry and Molecular Biology·Seung Min Oh, Kyu Hyuck Chung
Mar 18, 2006·Best Practice & Research. Clinical Obstetrics & Gynaecology·Gudrun Rieck, Alison Fiander
Sep 7, 2005·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Xuan-Bich TrinhWiebren A A Tjalma
Aug 24, 2002·American Journal of Obstetrics and Gynecology·Puthugramam K Natrajan, R Don Gambrell
May 16, 2003·American Journal of Obstetrics and Gynecology·John Eden
Aug 24, 1999·American Journal of Obstetrics and Gynecology·P K NatrajanR D Gambrell
Jan 31, 2002·Oncology Nursing Forum·Debra BartonJeff Sloan
Jan 1, 2012·Climacteric : the Journal of the International Menopause Society·Amos Pines
Apr 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N F ColJ Lau
Jun 12, 2017·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Xinnian YuShanliang Zhong
Oct 3, 2002·The Medical Journal of Australia·Eva M DurnaJohn A Eden
Apr 17, 2003·The Medical Journal of Australia·Theresa M HayesMartin H N Tattersall
Apr 16, 2021·Endocrine Reviews·Valerie A FloresJoAnn E Manson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.